Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858

Vicki Morrison

Research output: Contribution to journalComment/debatepeer-review

Fingerprint

Dive into the research topics of 'Myeloid growth factors: To use or not to use, that is the question: Commentary on: Rabinowitz et al. Severe neutropenia in CHOP occurs most frequently in cycle 1: A predictive model. Leuk Lymphoma 2006;47:853-858'. Together they form a unique fingerprint.